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Transcellular biosynthesis of lipoxin A4 during adhesion of platelets
and neutrophils in experimental immune complex glomerulonephritis.
Polymorphonuclear neutrophils are important effectors of injury in host
defense and inflammation. Many inflammatory diseases are self-limiting,
raising the possibility that compounds are generated in vivo during the
course of inflammation that inhibit neutrophil recruitment and tissue
destruction. Lipoxins, a more recent addition to the families of bioactive
eicosanoids, are potential candidates in this regard. Lipoxins are gener-
ated via pathways that initially involve the dual lipoxygenation of arachi-
donic acid and are potent inhibitors of several neutrophil trafficking events
in Vitro. Here, we present evidence that lipoxin A4 is generated in rat
kidneys during experimental immune complex-mediated glomerulone-
phritis in vivo. Renal lipoxin A4 levels were markedly reduced by prior
depletion of animals of either neutrophils or platelets, suggesting that
most lipoxin A4 generated in vivo was derived from transcellular biosyn-
thetic pathways during platelet-neutrophil interactions. Electron micro-
scopic examination of glomerulonephritic kidneys revealed areas of
intimate contact between neutrophils and platelets within the lumen of
glomerular capillaries. P-selectin on platelets is an important mediator
of platelet-neutrophil adhesion in vitro and in vivo. Prior treatment of
animals with a blocking monoclonal antibody (mAb) against P-selectin
(mAb CY1747), but not an isotype-matched non-blocking control mAb
(mAb PNB1.6), caused striking inhibition of lipoxin A4 generation without
attenuating neutrophil recruitment. Anti-P-selectin niAb also blunted
transcellular lipoxin A4 generation during coincubations of activated
neutrophils and platelets in vitro. Together, these data suggested that
adhesion of activated platelets and neutrophils through P-selectin within
glomerular capillaries enhances transcellular lipoxin A4 formation by
priming lipoxygenase pathways of adherent cells and/or by facilitating the
transfer of arachidonate intermediates between adherent platelets and
neutrophils. Lipoxin A4 inhibits neutrophil chemotaxis, adhesion to endo-
thelial cells and diapedesis in some in vitro systems, and exposure of
neutrophils to lipoxin A4 er vivo in the present study resulted in striking
attenuation of their recruitment to inflamed glomeruli. These observations
provide evidence that neutrophil adhesion, in addition to facilitating
neutrophil recruitment during the initial stages of inflammation, also
promotes transcellular generation of lipid-derived signals that regulate
neutrophil trafficking and may contribute to the suppression of neutrophil-
mediated tissue injury.
Leukocyte adhesion to endothelial cells and other tissue com-
ponents is essential for leukocyte recruitment in host defense,
inflammation, thrombosis, and other vascular events [reviewed in
1]. In addition, leukocyte adhesion may promote tissue injury
during inflammation by facilitating the generation of reactive
oxygen species, degranulation, antigen presentation, and the
generation of pro-inflammatory mediators such as leukotrienes [1,
2]. Since inflammatory responses often resolve without therapeu-
tic intervention, it is likely that inhibitors of leukocyte adhesion
are generated in vivo that limit leukocyte recruitment and prevent
unchecked destruction of host tissue. Several lines of in vitro
evidence suggest that lipoxins may be important lipid-derived
modulators of leukocyte trafficking in inflammation [3—9]. Li-
poxins are eicosanoids formed via biosynthetic pathways that
initially involve the dual lipoxygenation of arachidonic acid by
either 5- and 15-lipoxygenases or 5- and 12-lipoxygenases (hence,
the trivial name litixygenase interaction products) [3, 4]. They
possess biochemical structures and spectra of bioactions distinct
from other classes of lipoxygenase-derived eicosanoids [3, 4]. We
recently demonstrated that lipoxin A4 (5S,6R,15S-trihydroxy-
7,9,13-trans-11-cis-eicosatetraenoic acid)(LXA4), at nanomolar con-
centrations inhibits leukotriene-induced neutrophil-endothelial
cell adhesion supported by 2 integrins and P-selectin via distinct
actions with neutrophils and endothelial cells, respectively [5]. In
addition, LXA4 attenuates neutrophil chemotaxis in vitro and
neutrophil migration across endothelial and epithelial cell mono-
layers induced by a variety of lipid and/or peptide mediators [6—9].
In the present study, we assessed LXA4 generation in acute
glomerulonephritis, a paradigm of renal inflammation, and de-
fined the relative contributions of leukocyte and transcellular
biosynthetic pathways to LXA4 generation in this setting. We
explored the influence of cell-cell adhesion on these biosynthetic
events and examined the impact of LXA4 on neutrophil trafficking
in acute glomerular inflammation.
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Induction of experimental immune complex-mediated
glomerulonephritis
Acute immune complex-mediated glomerulonephritis was in-
duced in the left kidneys of adult male Sprague-Dawley rats (150
1295
1296 Papayianni et al: Lipoxin synthesis in glomerulonephritis
to 175 g) by perfusion of left renal artery with 0.8 mg of a
conjugate of Concanavalin-A and native ferritin (Con-A/ferritin)
for two minutes and subsequent intravenous injection of rabbit
anti-ferritin antibody (2 ml), as detailed previously [101. The right
kidney is relatively spared of disease in this model and serves as an
internal control. Tissue fixation, staining light, immunofluores-
cence and electron microscopy, and assessment of glomerular
neutrophil infiltration by the dichloroacetate esterase reaction
were performed as reported previously [101. In some experiments,
animals were selectively depleted of either neutrophils or platelets
by treatment with anti-neutrophil or anti-thrombocyte sera, re-
spectively (each 1.5 ml i.p.; Accurate Chemical and Scientific
Corp., Westbury, NY, USA) 18 hours prior to induction of GN. In
other experiments designed to define the role of P-selectin in
neutrophil recruitment and transcellular LXA4 generation, ani-
mals were infused intravenously with a blocking anti-P-selectin
mAb (CY 1747, also designated PB1.3, 4 mg/kg of body wt, IgGi) or
an isotype-matched non-blocking anti-P-selectin mAb (PNB1.6,
IgGi) five minutes prior to administration of anti-ferritin antibody.
Lipoxin A4 levels
LXA4 levels were monitored in renal homogenates (Polytron
PT-MR3000, 3 strokes, 4°C), as an index of LXA4 generation,
using a recently developed ELISA for LXA4 (Oxford Biomedical
Research, Inc., Oxford, MI, USA) [11]. This ELISA has a lower
limit of detection for LXA4 of 90.8 fmol/ml and cross-reactivities
with other lipoxygenase products as follows: LXB4 1%; 15-HETE
0.1%; 5-HETE, 12-HETE, leukotrienes, each <0.1% [11]. For
assessment of transcellular LXA4 generation in vitro, rat neutro-
phils and platelets were isolated from heparinized and citrated
venous blood, respectively, as previously described for human
cells [12]. LXA4 levels were assessed by ELISA in supernatants of
coincubations of neutrophils and platelets (neutrophil : platelet
ratio 1:100; platelet density 3 x 109/ml) 20 minutes after stimu-
lation with the chemotactic peptide fMLP (10 M) and thrombin
(1 U/mI) in the presence of anti-P-selectin (CY 1747) or control
rnAb (each 10 ig/ml).
Assessment of neutrophil recruitment during acute
glomerulonephritis in vivo
Lipoxins may potentially modulate neutrophil recruitment in
vivo directly by affecting neutrophil chemotaxis and/or adhesion to
endothelial cells, or indirectly by influencing vascular tone and
intraglomerular shear stress (Discussion). To explore the possi-
bility that LXA4 directly inhibits neutrophil trafficking in glomer-
ulonephritis, rat neutrophils were isolated from heparinized blood
by standard procedures of Ficoll-Hypaque density gradient cen-
trifugation followed by dextran sedimentation, as described pre-
viously for human neutrophils [12, 13]. Contaminating red blood
cells were removed by hypotonic lysis and neutrophils were
suspended in Dulbecco's phosphate-buffered saline (PBS) at a
density of 5 x 106/ml. Neutrophils were radiolabeled with 111in-
dium by incubation with 11indium oxine (1 Ci/106 cells;
Mediphysics, IL, USA) for thirty minutes at room temperature,
washed three times in PBS and the final preparation was sus-
pended in PBS at a concentration of 5 X 106 cells/ml. Radiola-
beled neutrophils (10 X 106 in 2 ml of PBS) were exposed to
LXA4 (10—v M, 15 mm, 37°C) or its diluent, washed and injected
into rats five minutes prior to injection of anti-ferritin antibody.
Fig. 1. Morphologic characteristics and renal LXA4 levels in the Con-A!
ferritin model of acute immune complex-mediated glomendonephritis. A-C.
Structural details of the inflammatory process in the glomerulus of rat with
active glomerulonephritis 15 minutes after administration of anti-ferritin
antibody. D and E. Equivalent structures in control animals. The glomer-
ulus depicted in Panel A (hematoxylin and eosin) shows hypercellularity of
the glomerular tuft predominantly due to infiltrating neutrophils. The
inflammatory cells are positive for dichloroacetate esterase, as evidenced
by the red reaction product, depicted in Panel B (see Fig. 3 for quantita-
tion). The inflammation is initiated by immune complex formation along
glomerular and to a lesser extent peritubular capillary walls, as illustrated
in Panel C, which shows characteristic granular deposits containing rabbit
immunoglobulin G (IgG) (direct immunofluorescence microscopy with
FITC-anti-rabbit IgG). F. LXA4 levels, as determined by ELISA [11], in
renal homogenates prepared fifteen minutes after induction of acute
glomerulonephritis, a time at which platelet and neutrophil infiltration has
occurred [10]. The induction of glomerulonephritis was associated with a
marked increase in renal LXA4 levels, a change not observed in sham-
operated controls. Rats were selectively depleted of platelets or neutro-
phils to define the relative contributions of neutrophil or transcellular
pathways to LXA4 generation. Both neutrophil depletion and platelet
depletion reduced renal LXA4 levels, suggesting that most LXA4 was
formed by transcellular routes by neutrophil-platelet interactions. A
reduction in LXA4 levels would be expected in neutrophil-depleted, but
not platelet-depleted animals, if most LXA4 was generated either by
neutrophils alone or through their interactions with other cells within
glomeruli. Magnifications are 510X. LXA4 levels are means SE and are
expressed as ng/kidney and an asterisk represents a statistically significant
reduction (°P < 0.05 for neutrophil depletion and ** < 0.025 for platelet
depletion) when compared with acute glomerulonephritis.
Kidneys were harvested 15 minutes after induction of disease and
their radioactivity was measured in a y-counter (LKB Clinig-
amma) as an index of neutrophil recruitment.
Monoclonal antibodies
CY1747 (PB1.3) and PNB1.6 are murine monoclonal antibod-
ies against P-selectin whose specificity and functional character-
istics have been described previously [14]. Briefly, monoclonal
antibodies (both IgGi isotype) were raised by immunization of
RBF/DnJ mice with thrombin-activated human platelets and
partially purified human P-selectin, and isolation of hybridoma
clones. Both CY1747 and PNB1.6 react with recombinant human
P-selectin, purified P-selectin and thrombin-activated, but not
resting platelets, as determined by ELISA, immunoblotting and
flow cytometry [14]. In contrast, they do not react with either
E-selectin or L-selectin. Of particular relevance to the present
study, both monoclonal antibodies also react with activated rat
platelets, but not resting rat platelets or rat neutrophils, as
determined by flow cytometry. CY1747 inhibits adhesion of
activated rat platelets to rat neutrophils in mixed cell suspensions
in vitro, whereas PNB1.6 does not.
Statistics
Data are expressed as mean SEM. Differences between group
means were determined by analysis of variance and comparisons
between groups were made using a two-tailed Student's t-test. A P
value of <0.05 was taken to represent a statistically significant
difference between group means.
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Fig. 2. Electron microscopic examination of the Con Alferritin model of acute immune complex-mediated glomerulonephritis. The representative electron
micrograph in A shows a glomerular capillary loop from a glomerulonephritic animal with infiltrating neutrophils (PMN) and platelets (P) in close
contact and partially occluding the lumen. B. An equivalent examination of a normal animal (CL = capillary lumen; US = urinary space; Ep = visceral
epithelial cell; RBC = red blood cell; End = endothelial cell). Kidneys were prepared from glomerulonephritic animals 15 minutes after administration
of anti-ferritin antibody. Magnifications are 6600X.
Results
Detection of LXA4 levels in glomerulonephritic kidneys in vivo
In the Con-A/ferritin model of immune complex-mediated
glomerulonephritis, the Con-Alferritin conjugate localizes pre-
dominantly to the glomerular endothelium and lamina rara
interna of glomerular basement membrane [10]. Subsequent
administration of anti-ferritin antibody causes rapid immune
complex formation, complement activation, infiltration of glomer-
uli by platelets and neutrophils, and functional renal impairment
and morphologic injury that bear many of the hallmarks of human
acute glomerulonephritis (Fig. 1, A-C) [10, 15]. LXA4 levels were
monitored by ELISA in homogenates of glomerulonephritic
kidneys fifteen minutes after induction of disease (Fig. 1, A-C).
LXA4 was detected in nanogram quantities in glomerulonephritic
kidneys (Fig. iF). Significantly lower levels of LXA4 were de-
tected in contralateral kidneys which are relatively spared of
disease in this model, and LXA4 was virtually undetectable in
kidneys of either normal or sham-operated animals. Biosynthesis
of LXA4 occurred rapidly, being evident within five minutes of
injection of anti-ferritin antibody (data not shown).
Contribution of transcellular biosynthetic pathways to LXA4
generation in acute glomerulonephritis
Isolated human leukocytes in vitro generate LXA4, upon acti-
vation with receptor-mediated stimuli, through the actions of their
5- and 15-lipoxygenases [3, 4]. LXA4 generation is significantly
enhanced and new biosynthetic pathways are evoked in vitro when
neutrophils are stimulated in the presence of platelets [4, 12, 16,
17]. In the latter setting, platelets, which lack 5- and 15-lipoxyge-
nase activity, form LXA4 through the "15-oxygenase and LX
synthetase activity" of their 12-lipoxygenase with leukotriene A4
(LTA4), an epoxide intermediate produced by neutrophil 5-li-
poxygenase [4, 12, 16, 17]. In the present study, rats were depleted
of either neutrophils or platelets, using specific antisera, to define
the relative contributions of neutrophil and transcellular pathways
to LXA4 formation in acute glomerulonephritis. The number of
circulating leukocytes and platelets after each of these maneuvers
was as follows: circulating leukocytes in 10311.d: basal 6.5 0.7 (18
3% neutrophils), anti-neutrophil sera 3.1 0.9 (0.7 0.3%
neutrophils), anti-thrombocyte sera 4.9 0.8 (23.7 3.2%
neutrophils); circulating platelets in 1031p1: basal 752 94,
anti-thrombocyte sera 4 1, anti-neutrophil sera 462 51.
Neutrophil depletion and platelet depletion were independently
associated with marked reduction in renal LXA4 levels (Fig. iF),
suggesting that most LXA4 was generated within glomerular
capillaries by neutrophil-platelet interactions.
Platelet-neutrophil adhesion through P-selectin promotes
transcellular LXA4 generation in vivo
Electron microscopic examination of glomerulonephritic kid-
neys, performed in parallel with analyses of renal LXA4 genera-
tion, revealed platelets and neutrophils in close proximity within
the lumen of glomerular capillaries (Fig. 2A). Of interest, areas of
focal contact between platelets and neutrophils were frequently
observed (Fig. 2A).
P-selectin is a major platelet ligand that supports platelet-
neutrophil adhesion in vitro, modulates platelet-neutrophil inter-
actions during inflammation and thrombosis, and appeared a
likely substrate for platelet-neutrophil adhesion in our study [14,
ea1a wain
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Fig. 3. Impact of anti-P-selectin monoclonal antibody (mAb) on renal
LXA4 levels and neutrophil infiltration in glomerulonephritis in vivo and
LXA4 levels in neutrophil-platelet coincubations in vitro. A. Influence of
adhesion-blocking anti-P-selectin mAb (N = 4) and control non-blocking
mAb (N = 3) on renal LXA4 levels in Con-A/ferritin glomerulonephritis.
Anti-P-selectin mAb inhibited transcellular LXA4 generation in vivo (*P
< 0.05). B. The impact of anti-P-selectin mAb (N = 8) and platelet
depletion (N = 6) on glomerular neutrophil infiltration (expressed as
neutrophils per cross section of glomerulus) in Con-Alferritin glomerulo-
nephritis in vivo. For purposes of comparison, the effect of neutrophil
depletion on glomerular neutrophil counts is also provided (N = 4).
Platelet depletion, but not anti-P-selectin mAb afforded inhibition of
neutrophil infiltration (*P < 0.005), suggesting that anti-P-selectin mAb
blocked transcellular LXA4 generation by influencing platelet-neutrophil
interactions within the lumen of inflamed glomerular capillaries and not
by inhibiting neutrophil recruitment. C. The influence of anti-P-selectin (N
= 11) and control mAb (N 9) on transcellular LXA4 generation during
coincubations of rat platelets and neutrophils in vitro. As with acute
glomerulonephritis in vivo, LXA4 levels were significantly lower in Vitro
(*P < 0.005) in the presence of anti-P-selectin mAb, providing additional
evidence that P-selectin promotes transcellular LXA4 generation by
platelet-neutrophil interaction within a local milieu. Anti-P-selectin mAb
(CY 1747, also designated PB1.3, 4 mg/kg of body wt, [14]) waS adminis-
tered intravenously five minutes prior to administntion of anti-ferritin
antibody. Importantly, this mAb did not alter circulating leukocyte (6.7
0.5 103/pi; 18.3 1.4% neutrophils) or platelet counts (805 71 103/1.d).
LXA4 was measured by ELISA of renal homogenates prepared 15 minutes
after induction of disease, as described in Figure 1. Platelet and neutrophil
depletion were achieved using specific antisera as described in Figure 1.
The average number of neutrophils per cross section of glomerulus was
calculated by analysis of 20 glomeruli per kidney by two independent
observers in blinded fashion on paraffin sections stained by the dichloro-
acetate esterase reaction [10]. LXA4 levels were assessed by ELISA in
supernatants of coincubations of neutrophils and platelets (neutrophil:
platelet ratio 1:100; platelet density 3 x 109/ml) 20 minutes after stimu-
lation with the chemotactic peptide fMLP (l0- M) and thrombin (1 U/mI)
in the presence of anti-P-selectin (CY 1747) or control mAb (each 10
sgIml).
18—231. A specific monoclonal antibody (mAb) against an adhe-
sion epitope on P-selectin [141was used to probe the role of this
ligand in LXA4 biosynthesis in acute glomerulonephritis. Impor-
tantly, this mAb did not alter the number of circulating leukocytes
(6.7 0.5 i0/.tl; 18.3 1.4% neutrophils) or platelets (805 71
103/pd) when compared to untreated animals (vide supra). Prior
exposure of rats to this mAb, but not an isotype-matched non-
blocking control mAb, was associated with a striking decrement in
renal LXA4 levels during glomerular inflammation (Fig. 3A).
Importantly, anti-P-selectin mAb blocked LXA4 production with-
out affecting intrarenal deposition of Con-Alferritin or subse-
quent formation of immune complexes, as determined by immu-
nofluorescence microscopy (data not shown).
Peak platelet infiltration precedes peak neutrophil infiltration
in the Con-Alferritin model of glomerulonephritis [10] and neu-
trophil recruitment appeared dependent, at least in part, on the
presence of platelets in the present study as glomerular neutrophil
infiltration was reduced in glomerulonephritis following platelet
depletion (Fig. 3B). However, glomerular neutrophil infiltration
was not reduced by anti-P-selectin mAb (Fig. 3B). These obser-
vations suggested that platelet-neutrophil adhesion through P-
selectin promotes transcellular LXA4 generation within the local
intravascular milieu of inflamed glomeruli and not by facilitating
recruitment of neutrophils, the cell source of the arachidonate
intermediate (LTA4) for platelet LXA4 biosynthesis.
To explore this hypothesis further, the impact of anti-P-selectin
mAb on transcellular LXA4 biosynthesis was assessed in vitro
during coincubations of activated neutrophils and platelets. LXA4
biosynthesis was initiated by the simultaneous addition of the
chemotactic peptide fMLP (10—v M), a well-characterized recep-
tor-mediated stimulus for neutrophil activation, and thrombin (1
U/mI), a potent physiological stimulus for platelet activation.
LXA4 was not detectable in suspensions of platelets alone and
there was a striking increase in LXA4 generation in neutrophil-
platelet coincubations (0.44 0.09 ng/ml; N = 11) when com-
pared with suspensions of neutrophils alone (0.06 0.01 nglml;
N = 3). These findings suggest tlat rat platelets, like human
platelets [4, 121, possess "LX synthetase activity" and transform
the neutrophil-derived arachidonate intermediate LTA4 to LXA4
during cell-cell interactions. Again, transcellular biosynthesis of
LXA4 was significantly blunted by anti-P-selectin mAb, but not an
isotype-matched control antibody (Fig. 3C). Thus, parallel in vivo
and in vitro studies support a role for P-selectin in transcellular
LXA4 generation by platelet-neutrophil interacfions within a local
inflammatory milieu.
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Fig. 4. Influence of LXA4 on neutrophil trafficking to glomerulonephritic
kidneys in vivo. '11lndium-labeled neutrophils (10 X 10 in 2 ml of PBS)
were exposed to LXA4 (10 M, 15 mm, 37°C) or its diluent, washed and
injected into rats five minutes prior to injection of anti-ferritin antibody.
Exposure of tm11indium-labeled neutrophils to LXA4 did not affect their
levels of radioactivity when compared with exposure to diluent. Kidneys
were harvested 15 minutes after induction of disease and their radioac-
tivity was measured in a y-counter (LKB Clinigamma) as an index of
neutrophil recruitment. Data are means SE. *Denotes a statistically
significant difference (P < 0.001) when compared with renal radioactivity
in glomerulonephritic rats injected with diluent-treated neutrophils. Ex-
posure of rat neutrophils to LXA4 resulted in marked
inhibition of their trafficking to glomerulonephritic kidneys, supporting
the contention that this eicosanoid may function as an endogenous
inhibitor of leukocyte recruitment in vivo.
LXA4 inhibits neutrophil recruitment to inflamed glomeruli
in vivo
The influence of LXA4 on neutrophil accumulation in glomeru-
lonephritic kidneys was assessed to determine if LXA4 inhibits
neutrophil recruitment during inflammation in vivo. To this end,
neutrophils were isolated from healthy rats, radiolabeled with
11mindium, treated with LXA4 (10 M) or its diluent, and injected
intravenously five minutes prior to administration of anti-ferritin
antibody. The kidneys of glomerulonephritic animals displayed
markedly increased radioactivity when compared with those of
normal animals (Fig. 4), consistent with histologic assessments of
glomerular neutrophil infiltration (Figs. 1 and 2). Prior exposure
of neutrophils to LXA4 was associated with inhibition of neutro-
phil recruitment, supporting a modulatory role for LXA4 on
neutrophil trafficking in vivo.
Discussion
Acute immune complex-mediated glomerulonephritis is a par-
adigm of acute renal inflammation. Our results indicate that
LXA4 is generated in the kidney in the Con-A/ferritin model of
immune complex-mediated glomerulonephritis in nanogram
quantities, amounts that are likely to have potent modulatory
effects on neutrophil recruitment (vide infra). Significantly more
LXA4 was detected in glomerulonephritic kidneys than in con-
tralateral kidneys, which are relatively spared of disease, impli-
cating inflamed glomeruli as the major source of LXA4 in our
model. It is likely that the LXA4 detected in contralateral kidneys
reflects some, albeit lower grade, inflammation on that side or
detection of LXA4 released into the systemic circulation by
glomerulonephritic kidneys. The striking reduction in renal LXA4
levels following neutrophil depletion and platelet depletion pro-
vide compelling evidence for transcellular eicosanoid biosynthesis
in vivo and support previous in vitro predictions that transcellular
pathways may amplify the profile and levels of mediators gener-
ated within the vascular lumen during multicellular inflammatory
responses [2, 15, 24—27]. It is likely that the residual LXA4 levels
detected in platelet-depleted and neutrophil-depleted animals
reflect LXA4 biosynthesis by other leukocytes and/or by transcel-
lular routes during interactions of these leukocytes with other
glomerular cells that express appropriate lipoxygenase activity
[27].
Electron microscopic analysis of inflamed glomeruli demon-
strated neutrophil adhesion to endothelial cells, in keeping with
the well-defined role of adhesion in leukocyte recruitment [1, 28].
A more striking and novel pathologic finding was the direct
visualization of areas of platelet-leukocyte contact within capillary
lumens. The latter finding was even more intriguing given that
renal LXA4 generation was blunted by mAb against P-selectin, a
major ligand on platelets that supports platelet-neutrophil adhe-
sion. Together, these observations suggested that P-selectin-
mediated platelet-neutrophil adhesion facilitates transcellular li-
poxin biosynthesis in acute glomerular inflammation.
Whereas platelets appeared to contribute to early neutrophil
infiltration in acute glomerulonephritis, consistent with other
investigations [29] it is unlikely that P-selectin promoted transcel-
lular LXA4 biosynthesis simply by facilitating neutrophil recruit-
ment. In keeping with this interpretation, the number of neutro-
phils within inflamed glomeruli was reduced by prior depletion of
experimental animals of platelets, but not by treatment with
anti-P-selectin mAb. These findings suggest that platelets pro-
mote neutrophil infiltration by presenting adhesion molecules
other than P-selectin to neutrophils and/or by elaborating chem-
ical stimuli of neutrophil recruitment, and that platelet-neutrophil
adhesion through P-selectin then augments transcellular LXA4
biosynthesis within a local inflammatory milieu. They also indicate
that endothelial cell P-selectin is not a pivotal molecule in
neutrophil recruitment in this model. Indeed, immunohistochem-
ical staining revealed little up-regulation of endothelial cell P-
selectin expression within the temporal framework of our study
(data not shown).
There are several potential mechanisms by which P-selectin-
mediated adhesion could enhance LXA4 biosynthesis during local
platelet-neutrophil interactions in vivo. By approximating neutro-
phil and platelet cell membrane lipid bilayers, adhesion may
potentially facilitate the transfer of the arachidonate intermediate
LTA4 from neutrophils to platelets. In this regard, it is noteworthy
that LTA4 undergoes rapid non-enzymatic hydrolysis to biologi-
cally inactive products in aqueous media and that its stability is
significantly prolonged in a lipid environment [30]. Neutrophil
adhesion through P-selectin may also augment leukocyte 5-lipoxy-
genase pathways such that adherent neutrophils release greater
quantities of LTA4 upon activation. Indeed, P-selectin-mediated
adhesion was recently reported to enhance neutrophil oxidative
bursts in vitro, suggesting that engagement of this ligand may
prime neutrophil functional responses through "outside-in" sig-
nalling events [31]. It is likely that both mechanisms could
contribute to the stimulatory action of P-selectin on transcellular
eicosanoid generation in vivo.
16000'
12000 i
*
8000 m N8
4000 N=4
0
Control ON i-Vehicle ON + LXA4
Papayianni et al: Lipoxin synthesis in glomen4lonephritis 1301
The identification of LXA4 as a product of neutrophil-platelet
interactions was particularly provocative in view of the self-
limiting nature of renal injury in glomerulonephritis induced by
Con-A/ferritin [10] and recent evidence implicating LXA4 as a
potential inhibitor of leukocyte trafficking [5—9]. Neutrophils
express specific high affinity G-protein-coupled receptors for
LXA4 [31] and engagement of these receptors stimulates rapid
remodeling of cell membrane lipids without provoking homo-
typic or heterotypic neutrophil adhesion. Exposure of neutro-
phils to nanomolar concentrations of LXA4 in vitro attenuates
neutrophil chemotaxis, adhesion to endothelial cells, and/or
migration across endothelium induced by leukotrienes and
other chemoattractants [5—8]. Our results provide evidence
that LXA4 may also inhibit neutrophil recruitment during
inflammation in vivo. Indeed, it has been postulated that
lipoxins and leukotrienes exert opposing actions on neutrophil
trafficking within the vascular lumen in a manner akin to the
counter-regulatory actions of prostacyclin and thromboxane on
platelet activation [2, 331. The potential importance of LXA4 as
an immunomodulator is further supported by the recent detec-
tion of this eicosanoid in human inflammatory and allergic
diseases and vascular events [reviewed in 4]. Whereas our
results implicate neutrophil-platelet transcellular biosynthetic
routes as an important initial source of LXA4 during inflam-
mation, it is likely that cytokine-stimulated induction of 12- and
15-lipoxygenase activity in other cell-types further amplifies the
magnitude and efficiency of lipoxin generation in these settings
[34, 35]. The formation of LXA4 within the vascular lumen
during platelet-neutrophil interactions would ideally situate
this eicosanoid for modulation of leukocyte recruitment. In the
specific context of glomerular inflammation, intravascular
generation of LXA4 may also benefit renal blood flow and
glomerular filtration, since LXA4 induces endothelium-
dependent vasodilatation and opposes the intrarenal vasocon-
strictive actions of peptidoleukotrienes [361, which are proba-
ble important pro-inflammatory vasoactive mediators in acute
glomerulonephritis.
In summary, we present evidence that LXA4 is generated within
the vascular lumen during glomerular inflammation by transcel-
lular routes during neutrophil-platelet interactions and that ad-
hesion of platelets and neutrophils through platelet P-selectin
promotes transcellular LXA4 biosynthesis in this setting. Expo-
sure of neutrophils to LXA4 results in inhibited neutrophil
trafficking to glomerulonephritic kidneys, suggesting that cell-cell
interactions may promote the generation of endogenous lipid-
derived inhibitors that act on leukocyte trafficking during the
evolution of multicellular inflammatory responses to limit tissue
destruction. In this regard, our results add to an expanding body
of evidence implicating products of the 12- and 15-lipoxygenase
pathways (lipoxins, 15-hydroxyeicosatetraenoic acid) as "braking
signals" in the evolution of host defense and inflammatory
responses [37—42]. Definitive demonstration of a role for LXA4 as
a modulator of neutrophil recruitment will require the develop-
ment of pharmacologic or molecular strategies for specific inhi-
bition of LXA4 biosynthesis or bioactivity. The elucidation of the
signals generated by transcellular biosynthesis that down-regulate
multicellular inflammatory responses in vivo may suggest novel
strategies for therapeutic intervention in leukocyte-mediated hu-
man diseases.
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